Open access · US-GOV via ClinicalTrials.gov Clinical trial

Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)

Authors not listed

Imperial College London · 2013

Dysbiosis Human Randomized controlled trial

Abstract

Older adults are at increased risk of high blood pressure and cognitive decline. High blood pressure itself also increases risk of cognitive decline. A particular type of blood pressure lowering drug (a calcium channel blocker(CCB)) may lower risk of dementia in younger adults but there is no clear evidence of it's impact in those \>=80. It is important that we know whether CCB use impacts on cognitive function in this age group. This study will examine the impact of antihypertensives on change in cognitive function with a particular focus on CCBs.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-31 MST

Cite this

APA

Anonymous. (2013). Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG). <em>Imperial College London</em>. https://clinicaltrials.gov/study/NCT01868165

Vancouver

Anonymous. Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG). Imperial College London. 2013.

BibTeX

@misc{anon2013Assess, title = {Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)}, author = {Anonymous}, journal = {Imperial College London}, year = {2013}, }